Cargando…

Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Ludwig, H, Milosavljevic, D, Zojer, N, Faint, J M, Bradwell, A R, Hübl, W, Harding, S J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868335/ http://dx.doi.org/10.1038/leu.2013.25

Ejemplares similares

Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients
por: Ludwig, H, et al.
Publicado: (2013)

Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed/refractory patients with myeloma
por: Ludwig, Heinz, et al.
Publicado: (2016)

Lymphoplasmacytic Lymphoma with Only Lambda Light Chain Monoclonal Paraprotein Expression
por: Cautha, Sandhya, et al.
Publicado: (2022)

Immunoglobulin heavy/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patients
por: Batinić, Josip, et al.
Publicado: (2015)

Targeting Paraprotein Biosynthesis for Non-Invasive Characterization of Myeloma Biology
por: Lückerath, Katharina, et al.
Publicado: (2013)

Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients
por: Bradwell, A, et al.
Publicado: (2013)

Association between left ventricular function and paraprotein type in patients with multiple myeloma
por: Yi, Jeong-Eun, et al.
Publicado: (2017)

Ratio of involved/uninvolved immunoglobulin quantification by Hevylite™ assay: clinical and prognostic impact in multiple myeloma
por: Koulieris, Efstathios, et al.
Publicado: (2012)

Paraprotein interference with turbidimetric gentamicin assay
por: Dimeski, Goce, et al.
Publicado: (2015)

Serum neurofilament light chain, contactin-1 and complement activation in anti-MAG IgM paraprotein-related peripheral neuropathy
por: Amaador, Karima, et al.
Publicado: (2022)

Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure
por: Hutchison, Colin A, et al.
Publicado: (2008)

Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials
por: Lopez-Anglada, Lucia, et al.
Publicado: (2018)

Mouse myeloma cells that make short immunoglobulin heavy chains: pleiotropic effects on glycosylation and chain assembly
Publicado: (1984)

INDEPENDENT SYNTHESIS OF LIGHT AND HEAVY CHAINS : Quantitation of Light-Chain Production by Mouse Myeloma Variants
por: Laskov, Reuven, et al.
Publicado: (1974)

Corrigendum to: Heavy with child? Pregnancy status and stable isotope ratios as determined from biopsies of humpback whales
por: Clark, Casey T, et al.
Publicado: (2019)

Immunoglobulin heavy chain and binding protein complexes are dissociated in vivo by light chain addition
Publicado: (1990)

Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma
por: Suehara, Yasuhito, et al.
Publicado: (2017)

Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains
por: Sternke-Hoffmann, Rebecca, et al.
Publicado: (2023)

Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity
por: Guan, Jian, et al.
Publicado: (2015)

An Unusual Case of Lysosomal Paraprotein Accumulation in Glomerular Endothelial Cells
por: Taneda, Sekiko, et al.
Publicado: (2019)

Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia
por: Weaver, Allison, et al.
Publicado: (2020)

SYNTHESIS AND ASSEMBLY OF IMMUNOGLOBULINS BY MALIGNANT HUMAN PLASMACYTES : I. MYELOMAS PRODUCINGγ-CHAINS AND LIGHT CHAINS
por: Zolla, Susan, et al.
Publicado: (1970)

STRUCTURAL STUDIES OF HUMAN IMMUNOGLOBULINS : DIFFERENCES IN THE FD FRAGMENTS OF THE HEAVY CHAINS OF G MYELOMA PROTEINS
por: Frangione, Blas, et al.
Publicado: (1965)

Immunoglobulin Heavy Chain Exclusion in the Shark
por: Malecek, Karolina, et al.
Publicado: (2008)

ANTIGENIC RELATIONSHIPS BETWEEN IMMUNE GLOBULINS AND CERTAIN RELATED PARAPROTEINS IN MAN
por: Franklin, Edward C., et al.
Publicado: (1961)

Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients
por: Michallet, M, et al.
Publicado: (2018)

Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
por: Siegel, D S, et al.
Publicado: (2014)

Corrigendum to “Relationship between leukocyte, neutrophil, lymphocyte, platelet counts, and neutrophil to lymphocyte ratio and polymerase chain reaction positivity”. [Int. Immunopharmacol. 93 (2021) 107390]
por: Kabak, M., et al.
Publicado: (2021)

Immunoglobulin heavy chains in medaka (Oryzias latipes)
por: Magadán-Mompó, Susana, et al.
Publicado: (2011)

Clinicopathological Profile of Paraprotein-Associated Kidney Disease in Monoclonal Gammopathies: An Observational Study
por: Parepalli, Divya, et al.
Publicado: (2022)

Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis
por: Rathbone, Emma, et al.
Publicado: (2018)

Evaluating the screening value of serum light chain ratio, β(2) microglobulin, lactic dehydrogenase and immunoglobulin in patients with multiple myeloma using ROC curves
por: Ying, Limei, et al.
Publicado: (2023)

Corrigendum: Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective
Publicado: (2023)

Maturation of the Human Immunoglobulin Heavy Chain Repertoire With Age
por: Ghraichy, Marie, et al.
Publicado: (2020)

P835: IN SILICO PREDICTION REVEALS PUTATIVE T-CELL CLASS I/II NEOEPITOPES WITHIN THE CLONOTYPIC IMMUNOGLOBULIN HEAVY AND LIGHT CHAINS IN PATIENTS WITH MULTIPLE MYELOMA
por: Gkoliou, Glykeria, et al.
Publicado: (2023)

Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis”
por: Cherin, Patrick, et al.
Publicado: (2015)

Corrigendum to “There Is No Elevation of Immunoglobulin E Levels in Albanian Patients with Autoimmune Thyroid Diseases”
por: Latifi-Pupovci, Hatixhe, et al.
Publicado: (2022)

Clinical Validation of Immunoglobulin A Nephropathy Diagnosis in Swedish Biopsy Registers [Corrigendum]
Publicado: (2022)

Diffuse Normolipemic Plane Xanthomatosis with Immunoglobulin-Lambda Light-Chain Deposition in a Patient with Multiple Myeloma
por: Lee, Sul Hee, et al.
Publicado: (2019)

Role of serum‐free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma
por: Tacchetti, Paola, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_17jghe464dd268m4op038hnpk6